Firmenbeschreibung
IDEXX Laboratories Inc. fertigt Diagnose- und IT-Lösungen in den Bereichen Tiergesundheit, Wasser- und Milchqualität. Das Unternehmen unterstützt Tierarztpraxen dabei, ihre medizinische Versorgung weiterzuentwickeln und die Rentabilität der Einrichtungen zu steigern. Das Portfolio besteht aus diagnostischen Vor-Ort-Tests, Point-of-Care-Instrumenten, Referenzlabor-Diensten, digitalem Röntgen und Praxis-Management-Lösungen. Des Weiteren ist IDEXX in der Herstellung von mikrobiologischen Test-Technologien für sauberes Trinkwasser tätig und ist Top-Lieferant von diagnostischen Tests und Gesundheitsüberwachungssystemen für Milchsicherheit. Die Gesellschaft ist an über 60 Standorten weltweit vertreten und liefert an Kunden in über 175 Ländern. Der Hauptsitz ist Westbrook, Maine.
KeyData
endOfFinancialYear: | 31.12.2024 00:00 |
stockholderStructure: | BlackRock Inc. (10.9633%),Vanguard Group (10.144%),State Street Corporation (4.57328%),ALLIANCEBERNSTEIN L P (3.55716%),Fundsmith LLP (3.30428%),BAMCO INC NY (2.78495%),GEODE CAPITAL MANAGEMENT LLC (2.54792%),Franklin Resources Inc. (1.70223%),Invesco Ltd. (1.60629%),BLAIR WILLIAM CO IL (1.45452%) |
sharesOutstanding: | 82305898.0000 |
ceo: | Jay Mazelsky |
board: | Brian P. McKeon, Irene Chang Britt, Michael Lane, James F. Polewaczyk, Martin Smith, Sharon E. Underberg, Michael P. Johnson, Kerry Bennett, Mike Erickson, George J. Fennell, Ken Grady, John Hart, Dan Janson, Michael Schreck, Murthy Yerramilli |
supervisoryBoard: | Lawrence D. Kingsley, Bruce L. Claflin, Daniel M. Junius, Dr. Asha S. Collins, Dr. Sophie V. Vandebroek, Dr. Stuart M. Essig, Jay Mazelsky, Jonathan W. Ayers, M. Anne Szostak, Sam Samad, Irene Chang Britt |
countryID: | 20 |
freeFloat: | 57.2400 |
faceValue: | 0.1000 |
faceValueCurrencyID: | 4 |
faceValueCurrency: | USD |
sectorName: | Biotechnologie |
industryName: | Biotechnologie |
subsectorName: | Biotechnologie |
country: | USA |
countryName: | USA |
Kontakt
name: | John Ravis |
phone: | +1-207-556-8155 |
fax: | +1-207-556-4427 |
email: | investorrelations@idexx.com |
irWebSite: | is.gd/5WAHea |
Adresse
street: | One IDEXX Drive |
city: | Westbrook, Maine 04092, USA |
phone: | +1-207-556-0300 |
fax: | +1-207-556-4346 |
webSite: | www.idexx.com |
Finanzen (kurz)
year: | 2021 | cash: | 144.4540 |
balanceSheetTotal: | 2437.2030 | liabilities: | 1747.2110 |
shareCapital: | 10.6880 | totalShareholdersEquity: | 689.9920 |
sales: | 3215.3600 | investment: | 0.4000 |
incomeBeforeTaxes: | 902.6540 | netIncome: | 744.8450 |
cashFlow: | -239.4740 | employees: | 10350 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2022 | cash: | 112.5460 |
balanceSheetTotal: | 2746.7650 | liabilities: | 2138.0280 |
shareCapital: | 10.7190 | totalShareholdersEquity: | 608.7370 |
sales: | 3367.3240 | incomeBeforeTaxes: | 859.9720 |
netIncome: | 679.0890 | cashFlow: | -31.9080 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
year: | 2023 | cash: | 453.9320 |
balanceSheetTotal: | 3259.9250 | liabilities: | 1775.3950 |
shareCapital: | 10.7510 | totalShareholdersEquity: | 1484.5300 |
sales: | 3660.9530 | incomeBeforeTaxes: | 1061.1760 |
netIncome: | 845.0420 | cashFlow: | 341.3860 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
Finanzen (kurz)
year: | 2021 |
cash: | 144.4540 |
balanceSheetTotal: | 2437.2030 |
liabilities: | 1747.2110 |
shareCapital: | 10.6880 |
totalShareholdersEquity: | 689.9920 |
sales: | 3215.3600 |
investment: | 0.4000 |
incomeBeforeTaxes: | 902.6540 |
netIncome: | 744.8450 |
cashFlow: | -239.4740 |
employees: | 10350 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2022 |
cash: | 112.5460 |
balanceSheetTotal: | 2746.7650 |
liabilities: | 2138.0280 |
shareCapital: | 10.7190 |
totalShareholdersEquity: | 608.7370 |
sales: | 3367.3240 |
incomeBeforeTaxes: | 859.9720 |
netIncome: | 679.0890 |
cashFlow: | -31.9080 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2023 |
cash: | 453.9320 |
balanceSheetTotal: | 3259.9250 |
liabilities: | 1775.3950 |
shareCapital: | 10.7510 |
totalShareholdersEquity: | 1484.5300 |
sales: | 3660.9530 |
incomeBeforeTaxes: | 1061.1760 |
netIncome: | 845.0420 |
cashFlow: | 341.3860 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
Finanzen (ausführlich)
year: | 2022 | units: | 1000000 |
balanceSheetTotal: | 2746.7650 | cash: | 112.5460 |
currentAssets: | 1101.4770 | fixedAssets: | 1645.2880 |
liabilities: | 1235.8030 | totalLiabilitiesEquity: | 2746.7650 |
totalShareholdersEquity: | 608.7370 | property: | 649.4740 |
intangibleAssets: | 97.6720 | inventories: | 367.8230 |
accountsReceivable: | 400.6190 | accountsPayable: | 110.2210 |
liabilitiesTotal: | 2138.0280 | longTermDebt: | 694.3870 |
shortTermDebt: | 74.9820 | minorityInterests: | 0.0000 |
commonStock: | 10.7190 | sales: | 3367.3240 |
netIncome: | 679.0890 | operatingResult: | 898.7650 |
incomeInterest: | -38.7930 | investments: | 254.8200 |
incomeTaxes: | 180.8830 | costGoodsSold: | 1362.9860 |
grossProfit: | 2004.3380 | minorityInterestsProfit: | 0.0000 |
cashFlow: | 542.9840 | cashFlowInvesting: | -195.3500 |
cashFlowFinancing: | -370.9360 | cashFlowTotal: | -31.9080 |
accountingStandard: | US GAAP | equityRatio: | 22.1620 |
debtEquityRatio: | 1.2639 | liquidityI: | 0.0911 |
liquidityII: | 0.4152 | netMargin: | 20.1670 |
grossMargin: | 59.5232 | cashFlowMargin: | 16.1251 |
ebitMargin: | 26.6908 | ebitdaMargin: | 0.0000 |
preTaxROE: | 141.2715 | preTaxROA: | 31.3085 |
roe: | 111.5570 | roa: | 24.7232 |
netIncomeGrowth: | -8.8281 | revenuesGrowth: | 4.7262 |
taxExpenseRate: | 21.0336 | equityTurnover: | 5.5317 |
epsBasic: | 8.1200 | epsDiluted: | 8.0300 |
epsBasicGrowth: | -7.0938 | shareCapital: | 10.7190 |
incomeBeforeTaxes: | 859.9720 | priceEarningsRatioCompany: | 50.2414 |
priceCashFlowRatio: | 62.2878 | bookValuePerShare: | 7.3427 |
marketCap: | 33821259233.1600 | earningsYield: | 1.9904 |
pegRatio: | -7.0824 | cashFlowPerShare: | 6.5496 |
netAssetsPerShare: | 7.3427 | priceBookValueRatio: | 55.5597 |
priceEarningsRatio: | 49.8039 | netEarningsPerShare: | 8.1913 |
currency: | USD |
year: | 2023 | units: | 1000000 |
balanceSheetTotal: | 3259.9250 | cash: | 453.9320 |
currentAssets: | 1495.2540 | fixedAssets: | 1764.6710 |
liabilities: | 951.5470 | totalLiabilitiesEquity: | 3259.9250 |
totalShareholdersEquity: | 1484.5300 | property: | 702.1770 |
intangibleAssets: | 84.5000 | inventories: | 380.2820 |
accountsReceivable: | 457.4450 | accountsPayable: | 110.6430 |
liabilitiesTotal: | 1775.3950 | longTermDebt: | 622.8830 |
shortTermDebt: | 74.9970 | commonStock: | 10.7510 |
sales: | 3660.9530 | netIncome: | 845.0420 |
operatingResult: | 1097.1280 | incomeInterest: | -35.9520 |
investments: | 190.9510 | incomeTaxes: | 216.1340 |
costGoodsSold: | 1470.9830 | grossProfit: | 2189.9700 |
cashFlow: | 906.5100 | cashFlowInvesting: | -125.2540 |
cashFlowFinancing: | -441.9960 | cashFlowTotal: | 341.3860 |
accountingStandard: | US GAAP | equityRatio: | 45.5388 |
debtEquityRatio: | 0.4701 | liquidityI: | 0.4770 |
liquidityII: | 0.9578 | netMargin: | 23.0826 |
grossMargin: | 59.8197 | cashFlowMargin: | 24.7616 |
ebitMargin: | 29.9684 | ebitdaMargin: | 0.0000 |
preTaxROE: | 71.4823 | preTaxROA: | 32.5522 |
roe: | 56.9232 | roa: | 25.9221 |
netIncomeGrowth: | 24.4376 | revenuesGrowth: | 8.7200 |
taxExpenseRate: | 20.3674 | equityTurnover: | 2.4661 |
epsBasic: | 10.1700 | epsDiluted: | 10.0600 |
epsBasicGrowth: | 25.2463 | shareCapital: | 10.7510 |
incomeBeforeTaxes: | 1061.1760 | priceEarningsRatioCompany: | 54.5772 |
priceCashFlowRatio: | 50.8751 | bookValuePerShare: | 17.8667 |
marketCap: | 46118760924.0500 | earningsYield: | 1.8323 |
pegRatio: | 2.1618 | cashFlowPerShare: | 10.9101 |
priceBookValueRatio: | 31.0662 | priceEarningsRatio: | 54.5757 |
netEarningsPerShare: | 10.1703 | currency: | USD |
year: | 2024 | priceEarningsRatioCompany: | 49.8269 |
priceCashFlowRatio: | 46.4470 | bookValuePerShare: | 17.8667 |
marketCap: | 41707690752.5200 | earningsYield: | 2.0069 |
pegRatio: | 1.9736 | cashFlowPerShare: | 10.9101 |
netAssetsPerShare: | 17.8667 | priceBookValueRatio: | 28.3623 |
priceEarningsRatio: | 49.8256 | netEarningsPerShare: | 10.1703 |
currency: | USD |
Finanzen (ausführlich)
year: | 2022 |
units: | 1000000 |
balanceSheetTotal: | 2746.7650 |
cash: | 112.5460 |
currentAssets: | 1101.4770 |
fixedAssets: | 1645.2880 |
liabilities: | 1235.8030 |
totalLiabilitiesEquity: | 2746.7650 |
totalShareholdersEquity: | 608.7370 |
property: | 649.4740 |
intangibleAssets: | 97.6720 |
inventories: | 367.8230 |
accountsReceivable: | 400.6190 |
accountsPayable: | 110.2210 |
liabilitiesTotal: | 2138.0280 |
longTermDebt: | 694.3870 |
shortTermDebt: | 74.9820 |
minorityInterests: | 0.0000 |
commonStock: | 10.7190 |
sales: | 3367.3240 |
netIncome: | 679.0890 |
operatingResult: | 898.7650 |
incomeInterest: | -38.7930 |
investments: | 254.8200 |
incomeTaxes: | 180.8830 |
costGoodsSold: | 1362.9860 |
grossProfit: | 2004.3380 |
minorityInterestsProfit: | 0.0000 |
cashFlow: | 542.9840 |
cashFlowInvesting: | -195.3500 |
cashFlowFinancing: | -370.9360 |
cashFlowTotal: | -31.9080 |
accountingStandard: | US GAAP |
equityRatio: | 22.1620 |
debtEquityRatio: | 1.2639 |
liquidityI: | 0.0911 |
liquidityII: | 0.4152 |
netMargin: | 20.1670 |
grossMargin: | 59.5232 |
cashFlowMargin: | 16.1251 |
ebitMargin: | 26.6908 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 141.2715 |
preTaxROA: | 31.3085 |
roe: | 111.5570 |
roa: | 24.7232 |
netIncomeGrowth: | -8.8281 |
revenuesGrowth: | 4.7262 |
taxExpenseRate: | 21.0336 |
equityTurnover: | 5.5317 |
epsBasic: | 8.1200 |
epsDiluted: | 8.0300 |
epsBasicGrowth: | -7.0938 |
shareCapital: | 10.7190 |
incomeBeforeTaxes: | 859.9720 |
priceEarningsRatioCompany: | 50.2414 |
priceCashFlowRatio: | 62.2878 |
bookValuePerShare: | 7.3427 |
marketCap: | 33821259233.1600 |
earningsYield: | 1.9904 |
pegRatio: | -7.0824 |
cashFlowPerShare: | 6.5496 |
netAssetsPerShare: | 7.3427 |
priceBookValueRatio: | 55.5597 |
priceEarningsRatio: | 49.8039 |
netEarningsPerShare: | 8.1913 |
currency: | USD |
year: | 2023 |
units: | 1000000 |
balanceSheetTotal: | 3259.9250 |
cash: | 453.9320 |
currentAssets: | 1495.2540 |
fixedAssets: | 1764.6710 |
liabilities: | 951.5470 |
totalLiabilitiesEquity: | 3259.9250 |
totalShareholdersEquity: | 1484.5300 |
property: | 702.1770 |
intangibleAssets: | 84.5000 |
inventories: | 380.2820 |
accountsReceivable: | 457.4450 |
accountsPayable: | 110.6430 |
liabilitiesTotal: | 1775.3950 |
longTermDebt: | 622.8830 |
shortTermDebt: | 74.9970 |
commonStock: | 10.7510 |
sales: | 3660.9530 |
netIncome: | 845.0420 |
operatingResult: | 1097.1280 |
incomeInterest: | -35.9520 |
investments: | 190.9510 |
incomeTaxes: | 216.1340 |
costGoodsSold: | 1470.9830 |
grossProfit: | 2189.9700 |
cashFlow: | 906.5100 |
cashFlowInvesting: | -125.2540 |
cashFlowFinancing: | -441.9960 |
cashFlowTotal: | 341.3860 |
accountingStandard: | US GAAP |
equityRatio: | 45.5388 |
debtEquityRatio: | 0.4701 |
liquidityI: | 0.4770 |
liquidityII: | 0.9578 |
netMargin: | 23.0826 |
grossMargin: | 59.8197 |
cashFlowMargin: | 24.7616 |
ebitMargin: | 29.9684 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 71.4823 |
preTaxROA: | 32.5522 |
roe: | 56.9232 |
roa: | 25.9221 |
netIncomeGrowth: | 24.4376 |
revenuesGrowth: | 8.7200 |
taxExpenseRate: | 20.3674 |
equityTurnover: | 2.4661 |
epsBasic: | 10.1700 |
epsDiluted: | 10.0600 |
epsBasicGrowth: | 25.2463 |
shareCapital: | 10.7510 |
incomeBeforeTaxes: | 1061.1760 |
priceEarningsRatioCompany: | 54.5772 |
priceCashFlowRatio: | 50.8751 |
bookValuePerShare: | 17.8667 |
marketCap: | 46118760924.0500 |
earningsYield: | 1.8323 |
pegRatio: | 2.1618 |
cashFlowPerShare: | 10.9101 |
priceBookValueRatio: | 31.0662 |
priceEarningsRatio: | 54.5757 |
netEarningsPerShare: | 10.1703 |
currency: | USD |
year: | 2024 |
priceEarningsRatioCompany: | 49.8269 |
priceCashFlowRatio: | 46.4470 |
bookValuePerShare: | 17.8667 |
marketCap: | 41707690752.5200 |
earningsYield: | 2.0069 |
pegRatio: | 1.9736 |
cashFlowPerShare: | 10.9101 |
netAssetsPerShare: | 17.8667 |
priceBookValueRatio: | 28.3623 |
priceEarningsRatio: | 49.8256 |
netEarningsPerShare: | 10.1703 |
currency: | USD |